Jaguar Health (NASDAQ:JAGX) Shares Cross Above 50 Day Moving Average – Here’s Why

Jaguar Health, Inc. (NASDAQ:JAGX) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $1.01 and traded as high as $1.03. Jaguar Health shares last traded at $1.01, with a volume of 224,346 shares traded.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Jaguar Health from a “sell” rating to a “hold” rating in a report on Friday, September 13th.

Jaguar Health Trading Up 5.5 %

The business’s 50-day simple moving average is $1.01 and its two-hundred day simple moving average is $1.61. The company has a debt-to-equity ratio of 1.65, a current ratio of 1.84 and a quick ratio of 1.36.

Institutional Trading of Jaguar Health

A hedge fund recently bought a new stake in Jaguar Health stock. Virtu Financial LLC bought a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.22% of Jaguar Health at the end of the most recent reporting period. 12.04% of the stock is owned by institutional investors and hedge funds.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.